To clarify the anti-inflammatory effect of eicosa-pentaenoic acid (EPA), we investigated the effect of EPA administration on A23187-stimulated LTB
4 formation by rat leukocytes. LTB
4 is known to be an important mediator of inflammation and the decreased formation of LTB
4 is thought to be one of the important mechanism of anti-inflammatory effect of EPA. EPA ethyl ester (EPA-E) administration (100 mg, 300 mg and 1, 000 mg/kg/day) for 4 weeks dose dependently suppressed the formation of LTB
4 and increase in the formation of LTB
5 with the increase in EPA content in rat leukocytes. The content of docosapentaenoic acid (DPA) also dose-dependently increased and the content of arachidonic acid (AA) and docosahexaenoic acid (DHA) were decreased by the administration of 300 mg and 1000 mg of EPA-E daily. The formation of LTB
4 in stimulated leukocytes and the content of AA are positively correlated.
FMLP-induced chemotactic activity of leukocytes were suppressed with the EPA-E treatment but FMLP stimulated β-glucuronidase release was not affected by EPA administration.
In conclusion, highly purified EPA-E administration reduced the formation of proinflammatory LTB
4, increased the LTB
5, which would competitively inhibit the action of LTB
4 and suppressed the chemotactic activity of leukocytes, these might result in the suppression of inflammatory response.
抄録全体を表示